User profiles for William Tong

william m. tong

Rakuten
Verified email at rakuten.com
Cited by 5003

Memristor− CMOS hybrid integrated circuits for reconfigurable logic

…, GS Snider, G Medeiros-Ribeiro, RS Williams - Nano …, 2009 - ACS Publications
Hybrid reconfigurable logic circuits were fabricated by integrating memristor-based crossbars
onto a foundry-built CMOS (complementary metal−oxide−semiconductor) platform using …

[HTML][HTML] Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

…, T Curley, B MacGregore-Cortelli, W Tong… - Journal of clinical …, 2005 - ncbi.nlm.nih.gov
… Currently, there are multiple phase II studies in patients with hematologic and solid tumor
malignancies that are exploring the efficacy of daily and twice daily schedules that will help to …

Kinetics of surface growth: phenomenology, scaling, and mechanisms of smoothening and roughening

WM Tong, RS Williams - Annual Review of Physical Chemistry, 1994 - annualreviews.org
The growth of solid surfaces via vapor phase processes can be viewed as proceeding in
either of two directions: outward by physical or chemical deposition or inward by physical or …

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

…, NE Kemeny, LB Saltz, Y Huang, WP Tong… - Journal of clinical …, 1996 - ascopubs.org
PURPOSE To determine the response rate, survival, and toxicity of the new anticancer agent,
irinotecan (CPT-11), in the treatment of metastatic colorectal cancer. PATIENTS AND …

The prevalence of lymphogranuloma venereum infection in men who have sex with men: results of a multicentre case finding study

…, P French, D Ivens, C Ling, J Paul, W Tong… - Sexually transmitted …, 2009 - sti.bmj.com
… If you wish to reuse any or all of this article please use the link below which will take you to
the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and …

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial

…, C Aghajanian, P Sabbatini, W Tong… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Few chemotherapy agents are active in leiomyosarcoma (LMS), particularly LMS
that has progressed after doxorubicin treatment. We sought to determine the response to …

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously

…, T Curley, B MacGregor-Curtelli, W Tong… - Clinical Cancer …, 2003 - AACR
Purpose: To evaluate the safety, pharmacokinetics, and biological activity of suberoylanilide
hydroxamic acid (SAHA) administered by 2-h iv infusion in patients with advanced cancer. …

Vapor-phase self-assembled monolayer for improved mold release in nanoimprint lithography

…, DL Olynick, SY Wang, WM Tong, RS Williams - Langmuir, 2005 - ACS Publications
Resist adhesion to the mold is one of the challenges for nanoimprint lithography. The main
approach to overcoming it is to apply a self-assembled monolayer of an organosilane release …

17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/neu and Inhibits the Growth of Prostate Cancer Xenografts

…, B Higgins, D Verbel, G Heller, W Tong… - Clinical cancer …, 2002 - AACR
Purpose: Ansamycin antibiotics, including 17allylamino-17-demethoxygeldanamycin (17-AAG),
inhibit Hsp90 function and cause the selective degradation of signaling proteins that …

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

…, TM Berzin, CH Qiao, S Lin, WP Tong… - Clinical cancer research …, 1996 - AACR
A novel monoclonal antibody has been developed that reacts strongly with human prostatic
cancer, especially tumors of high grade. This antibody (7E11C-5) is currently in Phase 3 …